Insider · CIK 0001573235

Joshua Hexter

cooofficer

Files at ORMP (ORAMED PHARMACEUTICALS INC.). First filing Oct 2, 2026, latest Oct 2, 2026.

Track record

Not enough history

Fewer than three past buys with six months of prices.

Median 6-month excess

after past buys, n = 0

Hit rate

past buys that beat the index over 6 months

Open-market trades

0 / 1

$0 bought, $135k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ORMP: ORAMED PHARMACEUTICALS INC.

ORMPOct 9, 2026 · close 4.33

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

Score	Company	Value	Holdings	Price context	Filed
19Weak	ORMPsell 210b5-1 ORAMED PHARMACEUTICALS INC.	$135k 30,000 shares	-2%	+119% from low-16% from high	10 d ago

Transactions

Every row this insider has filed, newest first.

Date	Company	Transaction	Shares	Price	Value	Holdings after	Filed
Oct 1, 2026	ORMP ORAMED PHARMACEUTICALS INC.	SOpen-market sale Common Stock10b5-1	-30,000	$4.51	$135k	1,328,130	10 d ago
Sep 24, 2026	ORMP ORAMED PHARMACEUTICALS INC.	AGrant or award Common Stock	+75,455	-	-	1,148,839	17 d ago
Sep 24, 2026	ORMP ORAMED PHARMACEUTICALS INC.	AGrant or award Common Stock	+209,291	-	-	1,358,130	17 d ago
Sep 24, 2026	ORMP ORAMED PHARMACEUTICALS INC.	DDisposition to issuer Stock option (right to buy)derivative	-50,000	-	-	0	17 d ago
Sep 24, 2026	ORMP ORAMED PHARMACEUTICALS INC.	DDisposition to issuer Stock option (right to buy)derivative	-50,000	-	-	0	17 d ago
Sep 24, 2026	ORMP ORAMED PHARMACEUTICALS INC.	DDisposition to issuer Stock option (right to buy)derivative	-36,000	-	-	0	17 d ago
Feb 11, 2025	ORMP ORAMED PHARMACEUTICALS INC.	AGrant or award Common Stock	+45,000	$0.00	$0	751,333	Feb 11, 2025
Feb 11, 2025	ORMP ORAMED PHARMACEUTICALS INC.	AGrant or award Common Stock	+48,500	$0.00	$0	799,833	Feb 11, 2025
Feb 11, 2025	ORMP ORAMED PHARMACEUTICALS INC.	AGrant or award Common Stock	+33,334	$0.00	$0	833,167	Feb 11, 2025
Jan 2, 2025	ORMP ORAMED PHARMACEUTICALS INC.	AGrant or award Common Stock	+194,500	-	-	706,333	Jan 6, 2025
Nov 7, 2024	ORMP ORAMED PHARMACEUTICALS INC.	AGrant or award Common Stock	+30,000	-	-	511,833	Nov 8, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.